Large-scale loss-of-function C. elegans screens have demonstrated the profound flexibility of the aging schedule and identified major, conserved longevity pathways. A new challenge is to understand how longevity pathways work in the context of normal physiology, which will give us insight into the natural function of pathways controlling aging schedules and the genetic basis of naturally occurring disease states, and should lead to mechanistic insights that will allow us better control over disease and aging processes. In order to identify stable genetic polymorphisms in longevity pathways, we performed Quantitative Trait Loci (QTL) analysis using our rapid lifespan profiling platform (Chronos) to estimate lifespans across a panel of Bristol (N2) X Hawaiian (CB4856) Recombinant Inbred Lines (RILs) (Rockman et al, 2009). We identified a region on the left arm of Chromosome IV associated with variation in longevity. This region was further refined using a panel of Near Isogenic Lines (NILs) that contain short genomic fragments from the Hawaiian strain on the genetic background of the Bristol strain. Finally, using transgenic lines that rescue the longevity defect in our short-lived NILs, we identified two polymorphic genes,
set-15 and a close homolog to human casein kinase 1a, which shape the mortality schedule of C. elegans. Since
set-15 is a histone methyl transferase homolog, the polymorphism in
set-15 may influence longevity by regulating epigenetic modification of the genome. This is particularly interesting since the polymorphisms in the longevity-linked region have been linked to gene expression differences (expressionQTLs; eQTLs) across the genome. The regulation of these eQTLs provides a potential mechanism by which natural allelic variation can lead to large changes in gene expression and subsequently, longevity. Such natural variation likely contributes to differences in longevity observed in human populations, as well.